Abiopharma

Voyager to Present at Upcoming Investor Conferences

Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship

Aquestive Therapeutics to Participate in Upcoming September Investor Conferences

Sagimet Biosciences to Participate in Two Upcoming Investor Conferences

EyePoint Announces Participation at Upcoming Investor Conferences

Tango Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference

Unicycive Therapeutics to Participate in Upcoming Investor Events in September

Balchem Corporation to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025

Perspective Therapeutics to Participate in Upcoming September Conferences

Pulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid

Innoviva to Participate in Upcoming Investor Conferences

Lillys oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

Chemours Publishes 2024 Sustainability Report, Showcasing Latest Progress Against Its 2030 Goals

New Form 6-K - Immuron Ltd Filed: 2025-08-26 AccNo: 0001213900-25-080490 Size: 399 KB

New Form 8-K - Shattuck Labs, Inc. Filed: 2025-08-26 AccNo: 0001193125-25-188078 Size: 177 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits